Jennison Associates
ATRC icon

Jennison Associates’s AtriCure ATRC Stock Holding History

Jennison Associates’s Portfolio ATRC Stock Details ATRC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-593,270
Closed -$19.1M – 581
2025
Q1 		$19.1M Buy
+593,270
New +$22M 0.01% 341

Other funds holding ATRC

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
HRCM
Hood River Capital Management Palm Beach Gardens, Florida $13.8B AUM 163.97% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $3.89B AUM 16.15% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

Jennison Associates's ATRC Position: Q2 2025 in Review

Jennison Associates sold out of AtriCure (ATRC) in Q2 2025, closing a stake of 593,270 shares — an estimated $19.1M sold.

Jennison Associates first reported a position in ATRC in Q1 2025 and held it in 1 quarter. The position peaked at $19.1M in Q1 2025. 201 funds tracked by Wall St. Rank hold ATRC as of Q2 2025.

  • Jennison Associates reported no remaining AtriCure position as of Q2 2025 after selling out during the quarter.
  • Jennison Associates sold 593,270 AtriCure shares in Q2 2025, an estimated $19.1M.
  • Jennison Associates first reported a position in AtriCure in Q1 2025 and held it in 1 quarter.
  • Jennison Associates's AtriCure position peaked at $19.1M in Q1 2025.
  • 201 funds tracked by Wall St. Rank held AtriCure as of Q2 2025.

Based on Jennison Associates's 13F filing for Q2 2025, filed 1 Aug 2025.